Saudi Press

Saudi Arabia and the world
Saturday, Jun 21, 2025

COVID-19: Delaying second dose of Pfizer jab may leave elderly at risk of catching South African variant, study suggests

COVID-19: Delaying second dose of Pfizer jab may leave elderly at risk of catching South African variant, study suggests

Lab tests showed that one dose of the vaccine may not stimulate the immune system to produce enough antibodies to kill the virus.

Delaying the second dose of the Pfizer jab – the current government strategy - may leave some elderly patients at risk of infection by the South African variant, new research suggests.

Lab tests by scientists at Cambridge University showed that one dose of the vaccine may not stimulate the immune system to produce enough antibodies to kill the virus.

Only after a second dose would antibody levels be protective, according to preliminary data in the study, which has not yet been peer-reviewed.

Meanwhile, the South African variant has a mutation called E484K that helps it evade the immune system.

SOUTH AFRICAN VARIANT CASES



Some samples of the Kent variant have now been detected with the same mutation.

The Cambridge researchers tested blood samples from 26 people, 15 of them over 80, who had received one dose of the Pfizer jab against synthetic versions of both variants.

Antibodies in all volunteers were sufficient to kill the Kent variant.

But when the E484K mutation was added 10 times more antibodies were needed to neutralise the virus.

According to researchers, seven people had antibody levels that were insufficient to kill the virus after one dose of the vaccine, all of them over 80.

Only after a second dose, given three weeks later, were their antibody levels boosted to a level that killed the virus.

The study comes on the day Sky News analysis showed the number of deaths in the second wave of COVID-19 infections has now overtaken the number from the first.

Dr Dami Collier, one of the co-investigators, said: "Our data suggest that a significant proportion of people aged over 80 may not have developed protective neutralising antibodies against infection three weeks after their first dose of the vaccine.

"But it's reassuring to see that after two doses, serum from every individual was able to neutralise the virus."

Professor Ravi Gupta, the lead researcher, said: "Our work suggests the vaccine is likely to be less effective when dealing with this (E484K) mutation.

"B1.1.7 [the Kent variant] will continue to acquire mutations seen in the other variants of concern, so we need to plan for the next generation of vaccines to have modifications to account for new variants.

"We also need to scale up vaccines as fast and as broadly as possible to get transmission down globally."

A Department for Health and Social Care (DHSC) spokesperson said the decision to change vaccine dosage intervals (to spread them further apart) had come after a "thorough review of data" which showed the Pfizer/BioNTech vaccine was 89% effective in protection against COVID between 15 to 21 days after the first dose.

A DHSC statement said today's study had "assessed just one aspect of immunity, on a small cohort" and that getting vaccines deployed as quickly as possible to those at risk remained "our number one priority".

It concluded: "The Government is closely following the guidance of the Joint Committee on Vaccination and Immunisation and the UK's four Chief Medical Officers, which recommends we prioritise first doses of vaccine for as many people as possible"

The E484K variant helps the coronavirus evade the immune system and was found in 11 samples of some 200,000 that have been sequenced.

Sky's science correspondent Thomas Moore said the discovery of the E484K mutation was a "worrying development," as it could reduce the effectiveness of COVID vaccines and could also mean those who had been previously infected could be re-infected.

He said the evolution of E484K meant the virus had effectively "developed a superpower" which enabled it to not only infect cells, but also to beat the immune system.

"It changes shape so antibodies don't recognise it in the same way, and the fact that this mutation has been now picked up in some samples of the Kent variant is a twist - a worrying development," said Thomas Moore.

Newsletter

Related Articles

Saudi Press
0:00
0:00
Close
Israel Confirms Assassination of Quds Force Commander in Tehran
16 Billion Login Credentials Leaked in Unprecedented Cybersecurity Breach
Senate hearing on who was 'really running' Biden White House kicks off
G7 Leaders Fail to Reach Consensus on Key Global Issues
Mass exodus in Tehran as millions try to flee following Trump’s evacuation order
Iranian Military Officers Reportedly Seek Contact with Reza Pahlavi, Signal Intent to Defect
Vietnam Emerges as Luxury Yacht Destination for Ultra‑Rich
China's Iranian Oil Imports Face Disruption Amid Escalating Middle East Tensions
Trump Demands Iran's Unconditional Surrender Amid Escalating Conflict
Israeli Airstrike Targets Iranian State TV in Central Tehran
President Trump is leaving the G7 summit early and has ordered the National Security Council to the Situation Room
Netanyahu Signals Potential Regime Change in Iran
Analysts Warn Iran May Resort to Unconventional Warfare
Iranian Regime Faces Existential Threat Amid Conflict
Energy Infrastructure Becomes War Zone in Middle East
Iran Conducts Ballistic Missile Launches Amid Heightened Tensions with Israel
Iran Signals Openness to Nuclear Negotiations Amid Ongoing Regional Tensions
Shock Within Iran’s Leadership: Khamenei’s Failed Plan to Launch 1,000 Missiles Against Israel
Trump's Anti-War Stance Tested Amid Israel-Iran Conflict
UK Deploys Jets to Middle East Amid Rising Tensions
Exiled Iranian Prince Reza Pahlavi Urges Overthrow of Khamenei Regime
Wreck of $17 Billion San José Galleon Identified Off Colombia After 300 Years
Iran Launches Extensive Missile Attack on Israel Following Israeli Strikes on Nuclear Sites
Israel Issues Ultimatum to Iran Over Potential Retaliation and Nuclear Facilities
Black Box Recovered from Air India Crash Site
Coinbase CEO Warns Bitcoin Could Supplant US Dollar Amid Mounting National Debt
Trump to Iran: Make a Deal — Sign or Die
Operation "Like a Lion": Israel Strikes Iran in Unprecedented Offensive
Israel Launches 'Operation Rising Lion' Targeting Iranian Nuclear and Military Sites
Israeli Forces Intercept Gaza-Bound Aid Vessel Carrying Greta Thunberg
IMF Warns of Severe Global Trade War Impacts on Emerging Markets
Syria to Reconnect to Global Economy After 14 Years of Isolation
Israel Confirms Arming Gaza Clan to Counter Hamas Influence
Global News Roundup: From Ukraine's strategic military strikes and Russia's demands and Tensions Escalate in Ukraine, to serious legal issues faced by Britons in Bali and Trump's media criticism, the latest developments highlight a turbulent landscape
U.S. Reduces Military Presence in Syria
Trump Demands Iran End All Uranium Enrichment in Nuclear Talks
Iran Warns Europe Against Politicizing UN Nuclear Report
Paris Saint-Germain's Greatest Triumph Is Football’s Lowest Point
OPEC+ Agrees to Increase Oil Output for Third Consecutive Month
Turkey Detains Istanbul Officials Amid Anti-Corruption Crackdown
Meta and Anduril Collaborate on AI-Driven Military Augmented Reality Systems
EU Central Bank Pushes to Replace US Dollar with Euro as World’s Main Currency
European and Arab Ministers Convene in Madrid to Address Gaza Conflict
U.S. Health Secretary Ends Select COVID-19 Vaccine Recommendations
Trump Warns Putin Is 'Playing with Fire' Amid Escalating Ukraine Conflict
India and Pakistan Engage Trump-Linked Lobbyists to Influence U.S. Policy
U.S. Halts New Student Visa Interviews Amid Enhanced Security Measures
Trump Administration Cancels $100 Million in Federal Contracts with Harvard
SpaceX Starship Test Flight Ends in Failure, Mars Mission Timeline Uncertain
King Charles Affirms Canadian Sovereignty Amid U.S. Statehood Pressure
×